Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2003
12/03/2003EP1365776A2 Use of an adenosine a3 receptor agonist for inhibition of viral replication
12/03/2003EP1365775A1 Telithromycin suspension with a masked taste
12/03/2003EP1365772A2 Stabilized brivudine topical formulations containing metal oxide pigments
12/03/2003EP1365767A2 Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
12/03/2003EP1365764A1 Oral pharmaceutical composition of cefpodoxime proxetil
12/03/2003EP1365760A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/03/2003EP1365755A2 Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies
12/03/2003EP1365751A2 Granules and granules coated with a masked taste
12/03/2003EP1365739A1 Composition for rectal delivery of an oxazolidinone antibacterial drug
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1250125B1 Pharmaceutical compositions comprising terbinafine
12/03/2003EP1212336B1 Method for the production and use of spherical telithromycin clusters in the preparation of pharmaceutical forms
12/03/2003EP1187847B1 Streptogramin derivatives, preparation and compositions containing them
12/03/2003EP1124813B1 Microbial transformation product
12/03/2003EP1075483B1 Hygromycin a derivatives
12/03/2003EP0996464B1 Multivalent in ovo avian vaccine
12/03/2003EP0975369B1 Polyethylene glycol-interferon alpha conjugates for therapy of infections
12/03/2003EP0937070B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/03/2003EP0915898B1 Crystal form i of clarithromycin
12/03/2003EP0854715B1 Methods of inhibiting plasminogen activator inhibitor 1
12/03/2003EP0786455B1 Imidazole derivative
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003EP0694306B1 Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract
12/03/2003CN1460111A HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
12/03/2003CN1460109A Improved specificity in treatment of diseases
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460104A Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1460019A Improved injectable dispersions of propofol
12/03/2003CN1459459A Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of rainbow conk
12/03/2003CN1459301A Traditional Chinese medicinal plaster for treating cold
12/03/2003CN1459282A Method for prodn. of water soluble fluorophenylnicol
12/03/2003CN1459281A Medicine for preventing or treating AIDS, and prepn. and application thereof
12/03/2003CN1459280A Usage of immunopotentiation by using resveratrol
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129598C Itraconazole with improved solubility, method of preparing same and pharmaceutical composition for oral administration comprising same
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129454C DNA vaccine for foot and mouth disease
12/03/2003CN1129450C Medicine for clearing away heat and toxic material and its prepn.
12/03/2003CN1129442C Cold preventing and spleen invigorating paste
12/03/2003CN1129441C Medicine for curing metritis
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656936 Growth inhibitors of Candida albicans, and anti-HIV agents
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656924 Immunopotentiating compositions
12/02/2003US6656907 Method of treating gastric ulcer by administration of epidermal growth factor
12/02/2003US6656906 Hybrid polypeptides with enhanced pharmacokinetic properties
12/02/2003US6656727 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
12/02/2003US6656720 For use in vaccines
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656703 High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
12/02/2003US6656504 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656478 Cross-protective salmonella vaccines
12/02/2003US6656477 43 Kd protein vaccine and method for the production thereof
12/02/2003US6656476 Vaccine against Mumps containing a Jeryl-Lynn virus strain
12/02/2003US6656472 Multi oligosaccharide glycoconjugate bacterial meningitis vaccines
12/02/2003US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention
12/02/2003US6656467 Genetic engineering; administering immunoglobulins
12/02/2003US6656462 Interleukin-1 muteins useful as vaccine adjuvants
12/02/2003US6656459 Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof
11/2003
11/27/2003WO2003098223A2 A method for killing cells by inhibiting histone activity in the cell
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097844A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/27/2003WO2003097680A2 Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097657A1 An antimicrobial agent
11/27/2003WO2003097646A1 Acyl bicyclix derivatives of pyrrol
11/27/2003WO2003097644A2 Non-nucleoside reverse transcriptase inhibitors
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097616A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097595A1 Lactams used as anti-viral agents
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097163A2 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003WO2003097109A1 Improvements in delivery technology
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097094A1 Method of prophylaxis of infection
11/27/2003WO2003097091A2 Glucan-based vaccines
1 ... 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 ... 1798